NCT06976918View on ClinicalTrials.gov

Registry Platform Myelofibrosis and Anemia

Not yet recruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2031

Study Completion Date

September 30, 2031

Conditions

Primary MyelofibrosisSecondary MyelofibrosisPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia MyelofibrosisAnemiaMyelofibrosis; AnemiaMyelofibrosis

Trial Locations (1)

Unknown

Multiple sites all over Germany, Multiple Locations

All Listed Sponsors

collaborator

German Study Group for Myeloproliferative Neoplasms (GSG-MPN)

UNKNOWN

lead

iOMEDICO AG

INDUSTRY

NCT06976918 - Registry Platform Myelofibrosis and Anemia | Biotech Hunter | Biotech Hunter